Cargando…

Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer

PURPOSE: Prostate cancer and its treatment may affect patients’ sexual function and social wellbeing. This study investigated the relationship between social/family wellbeing and sexual health in patients with prostate cancer. Additionally, the moderating effect of clinical characteristics on this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rio, Carielle Joy, Goto, Taichi, Hsiao, Chao-Pin, Ross, Alexander L R, Saligan, Leorey N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625326/
https://www.ncbi.nlm.nih.gov/pubmed/37929256
http://dx.doi.org/10.2147/CMAR.S421951
_version_ 1785131110114525184
author Rio, Carielle Joy
Goto, Taichi
Hsiao, Chao-Pin
Ross, Alexander L R
Saligan, Leorey N
author_facet Rio, Carielle Joy
Goto, Taichi
Hsiao, Chao-Pin
Ross, Alexander L R
Saligan, Leorey N
author_sort Rio, Carielle Joy
collection PubMed
description PURPOSE: Prostate cancer and its treatment may affect patients’ sexual function and social wellbeing. This study investigated the relationship between social/family wellbeing and sexual health in patients with prostate cancer. Additionally, the moderating effect of clinical characteristics on this relationship was also explored. PATIENTS AND METHODS: This is a descriptive correlational study using baseline data of a longitudinal study enrolling 137 patients with prostate cancer. Sexual Function (SF) and Sexual Function Distress (SFD) data were collected using the Symptom Index questionnaire. Demographic data were obtained during study intake and clinical data were obtained from chart review. Bivariate correlation determined the correlations among continuous demographic/clinical data, social/family wellbeing, and sexual health. Moderated regression analysis determined the moderating effects of clinical characteristics on the relationship of social/family wellbeing and sexual health. RESULTS: Moderate positive correlation was found between social/family wellbeing and SF, whereas a weak negative correlation was noted between social/family wellbeing and SFD. Depression was significantly correlated with social/family wellbeing and SFD. Both sexual health domains were significantly correlated with Gleason score. A significant difference was noted in the social/family wellbeing and both SF and SFD in participants receiving androgen deprivation therapy (ADT) compared to those not receiving ADT. Concomitant ADT use was the only clinical characteristic found to be a significant moderator of the relationship between social/family wellbeing and SFD, but none of the clinical characteristics was found to have a moderating effect on the relationship of social/family wellbeing and SF. Among patients who were not receiving ADT, high social/family wellbeing was associated with low SFD. Patients who were receiving ADT reported slightly higher SFD despite having higher social/family wellbeing. CONCLUSION: Ensuring sexual health in patients with prostate cancer requires a comprehensive approach to address factors contributing to sexual health such as side effects of treatment and family wellbeing.
format Online
Article
Text
id pubmed-10625326
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106253262023-11-05 Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer Rio, Carielle Joy Goto, Taichi Hsiao, Chao-Pin Ross, Alexander L R Saligan, Leorey N Cancer Manag Res Original Research PURPOSE: Prostate cancer and its treatment may affect patients’ sexual function and social wellbeing. This study investigated the relationship between social/family wellbeing and sexual health in patients with prostate cancer. Additionally, the moderating effect of clinical characteristics on this relationship was also explored. PATIENTS AND METHODS: This is a descriptive correlational study using baseline data of a longitudinal study enrolling 137 patients with prostate cancer. Sexual Function (SF) and Sexual Function Distress (SFD) data were collected using the Symptom Index questionnaire. Demographic data were obtained during study intake and clinical data were obtained from chart review. Bivariate correlation determined the correlations among continuous demographic/clinical data, social/family wellbeing, and sexual health. Moderated regression analysis determined the moderating effects of clinical characteristics on the relationship of social/family wellbeing and sexual health. RESULTS: Moderate positive correlation was found between social/family wellbeing and SF, whereas a weak negative correlation was noted between social/family wellbeing and SFD. Depression was significantly correlated with social/family wellbeing and SFD. Both sexual health domains were significantly correlated with Gleason score. A significant difference was noted in the social/family wellbeing and both SF and SFD in participants receiving androgen deprivation therapy (ADT) compared to those not receiving ADT. Concomitant ADT use was the only clinical characteristic found to be a significant moderator of the relationship between social/family wellbeing and SFD, but none of the clinical characteristics was found to have a moderating effect on the relationship of social/family wellbeing and SF. Among patients who were not receiving ADT, high social/family wellbeing was associated with low SFD. Patients who were receiving ADT reported slightly higher SFD despite having higher social/family wellbeing. CONCLUSION: Ensuring sexual health in patients with prostate cancer requires a comprehensive approach to address factors contributing to sexual health such as side effects of treatment and family wellbeing. Dove 2023-10-31 /pmc/articles/PMC10625326/ /pubmed/37929256 http://dx.doi.org/10.2147/CMAR.S421951 Text en © 2023 Rio et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Rio, Carielle Joy
Goto, Taichi
Hsiao, Chao-Pin
Ross, Alexander L R
Saligan, Leorey N
Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer
title Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer
title_full Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer
title_fullStr Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer
title_full_unstemmed Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer
title_short Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer
title_sort family wellbeing and sexual health of patients receiving treatment for prostate cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625326/
https://www.ncbi.nlm.nih.gov/pubmed/37929256
http://dx.doi.org/10.2147/CMAR.S421951
work_keys_str_mv AT riocariellejoy familywellbeingandsexualhealthofpatientsreceivingtreatmentforprostatecancer
AT gototaichi familywellbeingandsexualhealthofpatientsreceivingtreatmentforprostatecancer
AT hsiaochaopin familywellbeingandsexualhealthofpatientsreceivingtreatmentforprostatecancer
AT rossalexanderlr familywellbeingandsexualhealthofpatientsreceivingtreatmentforprostatecancer
AT saliganleoreyn familywellbeingandsexualhealthofpatientsreceivingtreatmentforprostatecancer